Login
← Go Back
Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com
Stock Price vs Company Growth
1d
2.1%
1w
1.4%
1m
1.0%
3m
6.4%
6m
39.8%
1y
38.3%
5y
24.1%
10y
11.1%
all
1.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 11.4 2.1%
10.8
14.9
Company Overview
Sales
288 Cr
Growth: -12.5%
Profit after Tax
-328 Cr
Growth: -15.9%
Micro Cap
222 Cr
P/S: 0.8x
Industry P/S: 2.7x
Fundamentals
Sales (Cr) ₹ 288
Growth -12.5%
EBITDA N/A
P/S 0.8x
Dividend 0.0%
P/E N/A
Book Value ₹ 1
PEG Ratio N/A
ROE -1511.8%
P/B N/A
Shareholding Pattern
Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed
Nectar is a global pharmaceutical company specializing in Cephalosporins.
Belongs to (4 Indices)
Investors (30)
rajastha...
share.in...
religare...
Followers (2)
bhaskar6
sanjayda...